Gilead Sciences, Inc. revenue reports

Gilead Sciences, Inc. total revenue, net income and dynamics of changes in Euro today

Gilead Sciences, Inc. current income and income for the latest reporting periods. Net revenue Gilead Sciences, Inc. is now 6 217 000 000 €. Information about net revenue is taken from open sources. Net income Gilead Sciences, Inc. - 1 522 000 000 €. Information about net income is used from open sources. The financial graph of Gilead Sciences, Inc. shows the values and changes of such indicators: total assets, net income, net revenue. Gilead Sciences, Inc. financial report on the graph shows the dynamics of assets. A graph of the value of all Gilead Sciences, Inc. assets is presented in green bars.

Report date	Total revenue Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.	Net income Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
30/06/2021	5 763 171 434 € ↑	1 410 897 044 € ↓
31/03/2021	5 954 133 846 € ↑	1 602 786 458 € ↓
31/12/2020	6 879 281 842 € ↑	1 437 780 102 € ↓
30/09/2020	6 096 892 154 € ↑	333 720 720 € -
31/12/2019	5 449 844 758 €	2 499 197 392 €
30/09/2019	5 194 919 208 €	-1 079 957 330 €
30/06/2019	5 270 006 370 €	1 742 763 760 €
31/03/2019	4 895 497 562 €	1 830 828 950 €

Gilead Sciences, Inc. financial report charts

Gilead Sciences, Inc. quarterly report dates

Cost of revenue Gilead Sciences, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Gilead Sciences, Inc. is 1 390 000 000 € Total revenue Gilead Sciences, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Gilead Sciences, Inc. is 6 217 000 000 € Operating income Gilead Sciences, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Gilead Sciences, Inc. is 2 358 000 000 €

Net income Gilead Sciences, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Gilead Sciences, Inc. is 1 522 000 000 € Current assets Gilead Sciences, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Gilead Sciences, Inc. is 14 498 000 000 € Total assets Gilead Sciences, Inc. refers to the total amount of assets owned by a person or entity. Total assets Gilead Sciences, Inc. is 67 984 000 000 €

<	30/06/2021	31/03/2021	31/12/2020	30/09/2020	31/12/2019	30/09/2019	30/06/2019	31/03/2019
Gross profit Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.	4 474 638 654 €	4 692 484 124 €	6 400 021 808 €	5 039 182 872 €	3 889 700 392 €	4 235 472 138 €	4 343 004 370 €	4 008 356 648 €
Cost of revenue Cost of revenue is the total cost of producing and distributing of products and services of a company.	1 288 532 780 €	1 261 649 722 €	479 260 034 €	1 057 709 282 €	1 560 144 366 €	959 447 070 €	927 002 000 €	887 140 914 €
Total revenue Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.	5 763 171 434 €	5 954 133 846 €	6 879 281 842 €	6 096 892 154 €	5 449 844 758 €	5 194 919 208 €	5 270 006 370 €	4 895 497 562 €
Operating revenue Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.	-	-	-	-	-	-	-	-
Operating income Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).	2 185 870 716 €	2 746 706 926 €	3 630 139 832 €	2 940 450 344 €	1 754 814 786 €	-1 365 473 946 €	2 252 614 860 €	2 073 703 474 €
Net income Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.	1 410 897 044 €	1 602 786 458 €	1 437 780 102 €	333 720 720 €	2 499 197 392 €	-1 079 957 330 €	1 742 763 760 €	1 830 828 950 €
R&D spending Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.	1 045 658 256 €	977 987 110 €	1 308 926 824 €	1 073 468 316 €	1 018 775 198 €	4 625 739 980 €	1 075 322 320 €	979 841 114 €
Operating expense An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.	3 577 300 718 €	3 207 426 920 €	3 249 142 010 €	3 156 441 810 €	3 695 029 972 €	6 560 393 154 €	3 017 391 510 €	2 821 794 088 €
Current assets Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.	13 439 674 996 €	12 308 732 556 €	14 828 323 992 €	28 668 463 852 €	28 084 452 592 €	26 290 703 722 €	31 264 996 454 €	31 540 316 048 €
Total assets Total assets refers to the total amount of assets owned by a person or entity.	63 021 303 968 €	62 565 218 984 €	63 413 425 814 €	56 434 027 756 €	57 128 352 254 €	54 828 460 292 €	58 595 796 420 €	58 250 024 674 €
Current cash Current cash - the sum of all of the cash a company has on the date of report.	6 823 661 722 €	3 768 263 130 €	5 559 230 994 €	11 945 347 772 €	10 781 960 262 €	8 782 416 948 €	10 419 502 480 €	15 691 362 854 €
Current debt Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.	-	-	-	-	9 046 612 518 €	8 868 628 134 €	8 306 864 922 €	8 711 037 794 €
Total cash Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.	-	-	-	-	-	-	-	-
Total debt Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.	-	-	-	-	36 131 756 954 €	35 606 146 820 €	37 505 573 918 €	37 771 623 492 €
Debt ratio Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.	-	-	-	-	63.25 %	64.94 %	64.01 %	64.84 %
Shareholders equity Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.	18 271 209 420 €	17 568 541 904 €	16 873 290 404 €	16 171 549 890 €	20 880 720 050 €	19 099 949 208 €	20 965 077 232 €	20 348 620 902 €
Cash flow Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.	-	-	-	-	2 391 665 160 €	2 687 378 798 €	2 058 871 442 €	1 338 590 888 €

Last revenue report of Gilead Sciences, Inc. was 30/06/2021. According to last financial report total revenue in Gilead Sciences, Inc. was 5 763 171 434 Euro and changed by +9.36% since last year. Net income in Gilead Sciences, Inc. was 1 410 897 044 € in last quartal, net income changes to -19.0426%.

Current cash Gilead Sciences, Inc. - the sum of all of the cash a company has on the date of report. Current cash Gilead Sciences, Inc. is 7 361 000 000 €

All stocks today
Stock quotes
Stock market live
Historical stock prices
Stocks market capitalization
Dividend stocks
Stock earnings
Stock revenue
Stock ratings. Where to invest?
Full version		Contacts